Accident and Health, Fundraising, Life, Life and Health, News

Report: China Life invests US $42.4m in Series B round for Yingke Biopharmaceutic

Yingke was established in 2022 and is engaged in the R&D of pharmaceutical drugs

Editorial team

June 5, 2023

•

1 min read

New Standards.New Stage.Real Recognition. Entries Closing Soon. Apply now → Entries close
25 September

Unlock this insight for free

14 days of access to (Re)in Asia’s premium intelligence
Free daily briefing in your inbox each morning
No credit card required

Already have an account? Sign in →

Market conditions continue to evolve as businesses review their priorities and plans for growth. The pace of change varies across the region, with local factors shaping how organisations respond.

Attention is turning to the balance between near-term opportunities and longer-term objectives. Decisions made today will help determine how businesses adapt as conditions develop.

While the outlook remains varied, the broader direction reflects a market adjusting to new demands. The implications will become clearer over time as plans move into practice.

New Standards.New Stage.Real Recognition. Entries Closing Soon. Apply now → Entries close
25 September